PH Thrivers Day Course Overview

This educational activity is designed for patients living with pulmonary hypertension (PH), their families, caregivers, and support partners to enhance their understanding of pulmonary hypertension and empower them to actively participate in their care. Through presentations led by multidisciplinary experts and patient advocates, participants will gain practical knowledge about pulmonary hypertension, available treatment options, medication administration, oxygen therapy, research opportunities, lung transplantation, and strategies for maintaining quality of life. The program also emphasizes shared decision-making, patient perspectives, and meaningful engagement with the healthcare team to help participants navigate their PH journey with greater confidence and knowledge.

PH Thrivers Day Course Objectives

As a result of participation in this program, participants should be able to:

• Review the causes and effects of delayed referral for patients with pulmonary hypertension (PH).
• Evaluate the role of sotatercept, the newest “kid on the block,” in the management of patients with pulmonary hypertension.
• Discuss when to intervene in patients with pulmonary hypertension and left heart disease.
• Identify multidisciplinary management considerations for pregnant patients with pulmonary hypertension (PH).
• Analyze what we have learned as a program after 1 year of performing balloon pulmonary angioplasty in the treatment of patients with chronic thromboembolic pulmonary hypertension (CTEPH).
• Describe risk stratification and management of patients with pulmonary hypertension who are kidney and liver transplant candidates.
• Review the diagnosis and management of patients with pulmonary hypertension in the setting of interstitial lung disease.

Physician/APP Day Course Overview

This educational activity is designed for physicians, advanced practice providers, nurses, and other healthcare professionals involved in the care of patients with pulmonary hypertension to enhance their understanding of pulmonary hypertension, including its pathophysiology, at-risk populations, clinical presentation, diagnostic evaluation, and current treatment strategies. Special emphasis will be placed on multidisciplinary management, diverse patient populations, and emerging therapeutic and procedural approaches to care. Through a comprehensive review of evidence-based practices and evolving treatment options, participants will be better equipped to recognize pulmonary hypertension earlier, make informed clinical decisions, and optimize patient outcomes through timely diagnosis and appropriate management.

Physician/APP Day Course Objectives

As a result of participation in this program participants should be able to:

• Review the causes and effects of delayed referral for patients with pulmonary hypertension (PH).
• Evaluate the role of Sotatercept, the newest “kid on the block,” in the management of patients with pulmonary hypertension.
• Discuss when to intervene in patients with pulmonary hypertension and left heart disease.
• Identify multidisciplinary management considerations for pregnant patients with pulmonary hypertension (PH).
• Analyze what we have learned as a program after 1 year of performing balloon pulmonary angioplasty in the treatment of patients with chronic thromboembolic pulmonary hypertension (CTEPH).
• Describe risk stratification and management of patients with pulmonary hypertension who are kidney and liver transplant candidates.
• Review the diagnosis and management of patients with pulmonary hypertension in the setting of interstitial lung disease.

Event Details

WHEN

WHERE

PLANNER